Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.
Hosted on MSN
New hope for treating cardiac sarcoidosis
Stanford University is launching a Phase IIa trial to test baricitinib with a steroid-sparing medication for adults with active cardiac sarcoidosis. The study will track inflammation changes with ...
In a study of patients with cutaneous sarcoidosis, ECG abnormalities identified all cases of cardiac involvement, demonstrating 100% sensitivity and 100% negative predictive value. Researchers ...
GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT ...
Cardiovascular magnetic resonance (CMR) imaging may help physicians make decisions about which patients with suspected cardiac sarcoidosis require an implantable cardioverter-defibrillator (ICD) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results